Dr. Temple-Oberle is a University of Calgary Professor cross-appointed to the Departments of Oncology and Surgery, with a special interest in reconstructive plastic surgery. She completed her MD at Queen’s University, a plastic surgery residency at the University of Western Ontario, and fellowships at MD Anderson Cancer Center in reconstructive microsurgery and surgical oncology at the Tom Baker Cancer Centre. Prior to joining the University of Calgary team, Dr. Temple-Oberle worked in the Departments of Surgery and Oncology at University of Western Ontario from 2003 to 2011. During this time, she completed an MSc in Epidemiology at the Harvard School of Public Health. She has recently completed her Masters of Medical Education through the University of Dundee. Dr. Temple-Oberle’s current practice specializes in oncological reconstruction, particularly in breast cancer and melanoma. She conducts research focused on improving the quality of life for breast cancer survivors, integrating technology and ERAS protocols to improve surgical outcomes and patient experience, and medical treatment of in-transit melanoma. Her current focus is surgical prevention of lymphedema in cancer surgery patients by using microsurgical technique to reroute the lymphatic system through the venous system. In addition to her oncological work, Dr. Temple-Oberle is also an advocate for access to surgical treatment of body dysmorphia for transgender individuals.
Area of Focus
Summary of Research
- Popowich B, Kostaras X, Webb C, Temple-Oberle C. (Mis)understanding the treatment team and the measurement of outcomes in breast reconstruction. Eur J Surg Oncol. 2021 May;47(5):1228-1229. doi: 10.1016/j.ejso.2020.12.012. Epub 2020 Dec 19.
- Ince C, Temple-Oberle C, Leitao MM Jr, Coriddi M, Nelson G. Immediate lymphatic reconstruction: the time is right to prevent lymphedema following lymphadenectomy for vulvar cancer. Int J Gynecol Cancer. 2021 Jun;31(6):943. doi: 10.1136/ijgc-2021-002666. Epub 2021 Apr 15.
- Lopez-Obregon B, Barreto MP, Fyfe A, McKinnon G, Webb C, Temple-Oberle C. Evaluation of intra-lesional Interleukin 2 for the treatment of in-transit melanoma disease. Plast Surg (Oakv). 2021 Feb;29(1):4-9. doi: 10.1177/2292550320936669. Epub 2020 Jul 20. PMID: 33614534; PMCID: PMC7874363.
- Lafreniere AS, Shine JJ, Nicholas CR, Temple-Oberle CF. The use of indocyanine green and near-infrared fluorescence imaging to assist sentinel lymph node biopsy in cutaneous melanoma: A systematic review. Eur J Surg Oncol. 2021 May;47(5):935-941. doi: 10.1016/j.ejso.2020.10.027. Epub 2020 Oct 24.
- Percival G, Nicholas C, Webb C, Temple-Oberle C. Assessing exposure to dermoscopy in plastic surgery training programs. JPRAS Open. 2021;29:178-183. doi.org/10.1016/j.jpra.2021.05.003.
Area Of Focus
Summary Of Research
- Popowich B, Kostaras X, Webb C, Temple-Oberle C. (Mis)understanding the treatment team and the measurement of outcomes in breast reconstruction. Eur J Surg Oncol. 2021 May;47(5):1228-1229. doi: 10.1016/j.ejso.2020.12.012. Epub 2020 Dec 19.
- Ince C, Temple-Oberle C, Leitao MM Jr, Coriddi M, Nelson G. Immediate lymphatic reconstruction: the time is right to prevent lymphedema following lymphadenectomy for vulvar cancer. Int J Gynecol Cancer. 2021 Jun;31(6):943. doi: 10.1136/ijgc-2021-002666. Epub 2021 Apr 15.
- Lopez-Obregon B, Barreto MP, Fyfe A, McKinnon G, Webb C, Temple-Oberle C. Evaluation of intra-lesional Interleukin 2 for the treatment of in-transit melanoma disease. Plast Surg (Oakv). 2021 Feb;29(1):4-9. doi: 10.1177/2292550320936669. Epub 2020 Jul 20. PMID: 33614534; PMCID: PMC7874363.
- Lafreniere AS, Shine JJ, Nicholas CR, Temple-Oberle CF. The use of indocyanine green and near-infrared fluorescence imaging to assist sentinel lymph node biopsy in cutaneous melanoma: A systematic review. Eur J Surg Oncol. 2021 May;47(5):935-941. doi: 10.1016/j.ejso.2020.10.027. Epub 2020 Oct 24.
- Percival G, Nicholas C, Webb C, Temple-Oberle C. Assessing exposure to dermoscopy in plastic surgery training programs. JPRAS Open. 2021;29:178-183. doi.org/10.1016/j.jpra.2021.05.003.